Noble Drugs Limited
Produces and sells drugs, pharmaceuticals, and medical preparations.
1983 | Nashik, Maharashtra (India) | Active
Noble Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.91 M
- Company Age 42 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.73 Cr
- Revenue Growth 47802.33%
- Profit Growth -1657.10%
- Ebitda -1597.30%
- Net Worth
- Total Assets 2.40%
About Noble Drugs
Noble Drugs Limited (NDL) is a Public Limited Indian Non-Government Company incorporated in India on 21 March 1983 and has a history of 42 years and two months. Its registered office is in Nashik, Maharashtra, India.
The Corporate was formerly known as Noble Drugs P Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.91 M.
The company has closed loans amounting to ₹1.73 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dnyaneshwar Dhamne, Shriram Dhamne, and Vilas Dhamne serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100MH1983PLC029592
- Company No.
029592
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Mar 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Noble Drugs Limited
Explore comprehensive data for Noble Drugs Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Noble Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dnyaneshwar Dhamne  | Managing Director | 20-Nov-1983 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vilas Dhamne | Director | 01-Mar-1996 | Current |
| Shriram Dhamne | Director | 29-Jun-1995 | Current |
Financial Performance of Noble Drugs.
Noble Drugs Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 47802.33% increase. The company also saw a substantial fall in profitability, with a 1657.1% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noble Drugs?
In 2018, Noble Drugs had a promoter holding of 66.70% and a public holding of 33.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Professional Realtors Association Of Nashik Pran
Dnyaneshwar Dhamne is a mutual person
- Etash Life Sciences Limited Liability Pa Rtnership
Vilas Dhamne is a mutual person
- Spiti Construction Private Limited
Vilas Dhamne is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹1.73 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 1.16 Cr
- Bamk Of Indai : 0.51 Cr
- Rchants Co-Op Bnak : 0.04 Cr
- Maha Rashtra State Financeal Corporation : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2004 | Bank Of India | ₹0.67 M | Satisfied |
| 23 Jul 2002 | Bank Of India | ₹1.70 M | Satisfied |
| 18 Jun 2002 | Bank Of India | ₹2.37 M | Satisfied |
| 18 Jun 2002 | Bank Of India | ₹0.50 M | Satisfied |
| 18 Jun 2002 | Bamk Of Indai | ₹0.50 M | Satisfied |
How Many Employees Work at Noble Drugs?
Unlock and access historical data on people associated with Noble Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noble Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noble Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Noble Drugs
Recent activity within the organization
- Annual General Meeting
Noble Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Noble Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge registered on 17 Jun 1986 via Charge ID 90215074 with Maha Rashtra State Financeal Corporation was fully satisfied on 01 Mar 2012.
- Charges
A charge registered on 06 Mar 2004 via Charge ID 90211124 with Bank Of India was fully satisfied on 14 Nov 2011.
- Charges
A charge registered on 23 Jul 2002 via Charge ID 90213873 with Bank Of India was fully satisfied on 14 Nov 2011.
- Charges
A charge registered on 18 Jun 2002 via Charge ID 90215761 with Bamk Of Indai was fully satisfied on 14 Nov 2011.
Frequently asked questions
What is the Incorporation or founding date of Noble Drugs Limited?
Noble Drugs Limited was incorporated on 21 Mar 1983.
What is authorized share capital and paid-up capital of Noble Drugs Limited?
The authorized share capital of Noble Drugs Limited is ₹ 1.00 Cr and paid-up capital is ₹ 9.91 M.
Who are the current board members & directors of Noble Drugs Limited?
Currently 3 directors are associated with Noble Drugs Limited.
- Dnyaneshwar Jagannath Dhamne
- Shriram Jagannath Dhamne
- Vilas Bharat Dhamne
What is the registered address of Noble Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Noble Drugs Limited is Flat No.4, Ashirwad Apartment Sharanpur Road India, Nashik, Maharashtra, 422002.
What is the corporate identification number (CIN) and company number of Noble Drugs Limited?
The corporate identification number (CIN) of Noble Drugs Limited is U24100MH1983PLC029592 and the company number is 029592 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Noble Drugs Limited?
According to the financial reports for the fiscal year 2018, the revenue trend for Noble Drugs Limited has risen by 47802.33%.
When was the last Balance Sheet of Noble Drugs Limited filed with the ROC?
The most recent Balance Sheet for Noble Drugs Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records